Thomas Page PhD
Vice President, Engineering and Asset Development, Fujifilm Diosynth Biotechnologies
Dr. Page is currently the Vice President of Engineering and Asset Development at FUJIFILM Diosynth Biotechnologies. He has over 30 years of experience in Pharmaceutical Development, Manufacturing, Operations and Engineering in equity financed biotech, governmental partnerships and CDMO settings. His experience includes successfully devising and implementing the Engineering and Production strategy to support regulatory approvals in the U.S., EU, and other foreign jurisdictions for several large volume parenterals. He led design, construction, start up and operation for >15 substantial assets globally for blood products, antibodies, vaccines, viral vectors and plasmids. Is actively engaged with industry to push forward innovation in service to patient access and patient safety. Currently, he is leading a global standardization effort for all single use platforms for FDB (drug substance and drug product.)